| 2916.14.10 | 00 | Dicyclopentenyloxyethyl methacrylate | kg | Free | | 25% |
| 2916.14.20 | 10 | Ethyl methacrylate | kg | | | |
| 2916.14.20 | 20 | Methyl methacrylate | kg | | | |
| 2916.20.10 | 00 | (2,3,5,6-Tetrafluoro-4-methylphenyl)methyl- (1 α3 α)-(Z)-( ± )-3-(2-chloro-3,3,3-trifluoro-1- propenyl-2,2-dimethylcyclopropanecarboxylate) (Tefluthrin) | kg | Free | | 25% |
| 2917.19.30 | 00 | Ethylene brassylate | kg | 4.8% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P,SG) | 45% |
| 2917.32.00 | 00 | Dioctyl orthophthalates | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 3.2% (SG) | 15.4¡é/kg + 57% |
| 2917.33.00 | | Dinonyl or didecyl orthophthalates | | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 3.2% (SG) | 15.4¡é/kg + 57% |
| 2917.33.00 | 10 | Diisodecyl orthophthalate | kg | | | |
| 2917.34.01 | 10 | Dibutyl orthophthalate | kg | | | |
| 2917.37.00 | 00 | Dimethyl terephthalate | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX,P) 0.2¡é/kg + 2.9% (SG) | 15.4¡é/kg + 42% |
| 2918.18.00 | 00 | Chlorobenzilate (ISO) | kg | 6.5% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,L,MA,MX, P) 0.2¡é/kg + 3.3% (SG) | 15.4¡é/kg + 57% |
| 2918.23.10 | 00 | Salol (Phenyl salicylate) suitable for medicinal use | kg | 6.5% | Free (A,AU,BH,CA, CL,E,IL,J,JO, MA,MX, P,SG) | 15.4¡é/kg + 45% |
| 2922.49.10 | 00 | m-Aminobenzoic acid, technical; p-Aminobenzoic acid; 3,5-Diaminobenzoic acid; 2-Ethylamino-5-sulfobenzoic acid; 3-(N-Ethylanilino)propionic acid, methyl ester; β-( β-Methoxyethoxyethyl)-4-aminobenzoate; Methyl anthranilate; and l-Phenylalanine | kg | 5.8% | Free (A+,AU,BH, CA,CL,D,E,IL,J, JO,K,MA,MX, P,SG) | 15.4¡é/kg + 39% |
| 2926.90.16 | 00 | [1 α(S*),3 α(Z)]-( ± )-Cyano(3-phenoxyphenyl)- methyl 3-(2-chloro-3,3,3-trifluoro-1-propenyl)- 2,2-dimethylcyclopropanecarboxylate | kg | Free | | 15.4¡é/kg + 64.5% |
| 2930.90.91 | 07 | O,O-Diethyl S-[2-(diethylamino)- ethyl]phosphorothioate and its alkylated or protonated salts; and Thiodiglycol (INN) (bis(2-hydroxy- ethyl) sulfide) | kg | | | |
| 2930.90.91 | 20 | Isooctyl thioglycolate | kg | | | |
| 2933.33.00 | 00 | Alfentanil (INN), anileridine (INN), bezitramide (INN), bromazepam (INN), difenoxin (INN), diphenoxylate (INN), dipipanone (INN), fentanyl (INN), ketobemidone (INN), methylphenidate (INN), pentazocine (INN), pethidine (INN), pethidine (INN) intermediate A, phencyclidine (INN) (PCP), phenoperidine (INN), pipradrol (INN), piritramide (INN), propiram (INN) and trimeperidine (INN); salts thereof | kg | Free | | 15.4¡é/kg + 149.5% |
| 2933.39.61 | 10 | 3-Quinuclidinyl benzilate | kg | | | |
| 2933.49.17 | 00 | Ethyl ethyl-6,7,8-trifluoro-1,4-dihydro-4-oxo-3- quinolinecarboxylate | kg | Free | | 15.4¡é/kg + 52% |
| 2934.99.01 | 00 | Mycophenolate mofetil | kg | Free | | 15.4¡é/kg + 45% |
| 2935.00.13 | 00 | (5-[2-Chloro-4-(trifluoromethyl)phenoxy]-¡é/(methylsulfonyl)-2-nitrobenzamide) (Fomesafen); N-(2,6-Dichloro-3-methylphenyl)-5-amino-1,3,4- triazole-2-sulfonamide; 2,4-Dichloro-5-sulfamoylbenzoic acid; N-Ethyl-o-toluenesulfonamide; N-Ethyl-p-toluenesulfonamide; 7-(Hexadecylsulfonylamino)-1H-indole; Methyl 5-{[(4,6-dimethoxy-2-pyrimidinyl)amino]- carbonylaminosulfonyl}-3-chloro-1-methyl-1H- pyrazole-4-carboxylate (Halosulfuron methyl); and Mixtures of ortho- and para-toluene sulfonamides | kg | Free | | 15.4¡é/kg + 57.5% |
| 2936.25.00 | 00 | Vitamin B6 (Pyridoxine and related compounds with Vitamin B6 activity) and its derivatives | kg | Free | | 25% |
| 2936.26.00 | 00 | Vitamin B12 (Cyanocobalamin and related compounds with Vitamin B12 activity) and its derivatives | kg | Free | | 15.4¡é/kg + 145.5% |
| 2936.28.00 | 00 | Vitamin E (Tocopherols and related compounds with Vitamin E activity) and its derivatives | kg | Free | | 15.4¡é/kg + 63.5% |
| 3206.11.00 | 00 | Containing 80 percent or more by weight of titanium dioxide calculated on the dry matter | kg | 6% | Free (A,AU,BH, CA,CL,E,IL,J,JO, MA,MX, P,SG) | 30% |
